These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18618183)

  • 1. Analysis of clinical applicability of the breast cancer nomogram for positive sentinel lymph node: the canadian experience.
    Poirier E; Sideris L; Dubé P; Drolet P; Meterissian SH
    Ann Surg Oncol; 2008 Sep; 15(9):2562-7. PubMed ID: 18618183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive.
    Pal A; Provenzano E; Duffy SW; Pinder SE; Purushotham AD
    Br J Surg; 2008 Mar; 95(3):302-9. PubMed ID: 17876750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
    Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
    Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients.
    Scow JS; Degnim AC; Hoskin TL; Reynolds C; Boughey JC
    Cancer; 2009 Sep; 115(18):4064-70. PubMed ID: 19517477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
    Specht MC; Kattan MW; Gonen M; Fey J; Van Zee KJ
    Ann Surg Oncol; 2005 Aug; 12(8):654-9. PubMed ID: 16021535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.
    Orsoni M; Clerc J; Golfier F; Cortet M; Raudrant D; Krauth JS
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):334-7. PubMed ID: 21669485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population.
    Klar M; Jochmann A; Foeldi M; Stumpf M; Gitsch G; Stickeler E; Watermann D
    Breast Cancer Res Treat; 2008 Dec; 112(3):523-31. PubMed ID: 18172758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two models for the prediction of nonsentinel node metastases in breast cancer.
    Ponzone R; Maggiorotto F; Mariani L; Jacomuzzi ME; Magistris A; Mininanni P; Biglia N; Sismondi P
    Am J Surg; 2007 Jun; 193(6):686-92. PubMed ID: 17512277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?
    Unal B; Gur AS; Ahrendt G; Johnson R; Bonaventura M; Soran A
    Clin Breast Cancer; 2009 May; 9(2):92-5. PubMed ID: 19433389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.
    Gur AS; Unal B; Ozbek U; Ozmen V; Aydogan F; Gokgoz S; Gulluoglu BM; Aksaz E; Ozbas S; Baskan S; Koyuncu A; Soran A;
    Eur J Surg Oncol; 2010 Jan; 36(1):30-5. PubMed ID: 19535217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.
    Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ
    Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
    Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
    J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.